![David Feldman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Feldman
Oprichter bij GlyGenix Therapeutics, Inc.
Profiel
David Feldman is the founder of GlyGenix Therapeutics, Inc., where he holds the title of Chief Operating Officer & Director since 2006.
He is currently a Director at The UCAN Co.
Actieve functies van David Feldman
Bedrijven | Functie | Begin |
---|---|---|
GlyGenix Therapeutics, Inc.
![]() GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology GlyGenix Therapeutics, Inc. focuses on treating and curing Glycogen storage diseases. The firm’s services include development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen storage disease type 1a. The company was founded by David Feldman and Peter Kaufman in 2006 and is headquartered in Woodbridge, CT. | Oprichter | 01-01-2006 |
The UCAN Co.
![]() The UCAN Co. Food RetailRetail Trade The UCAN Co. manufactures energy drink for sports nutrition. The company is headquartered in Woodbridge, CT. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
GlyGenix Therapeutics, Inc.
![]() GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology GlyGenix Therapeutics, Inc. focuses on treating and curing Glycogen storage diseases. The firm’s services include development of nucleic acid molecules that compensate or correct the genetic defects that cause Glycogen storage disease type 1a. The company was founded by David Feldman and Peter Kaufman in 2006 and is headquartered in Woodbridge, CT. | Health Technology |
The UCAN Co.
![]() The UCAN Co. Food RetailRetail Trade The UCAN Co. manufactures energy drink for sports nutrition. The company is headquartered in Woodbridge, CT. | Retail Trade |